hookah charcoal, e-cigarettes, tobacco-free alternatives, and potentially
reduced exposure products (PREPs) now face scrutiny by the FDA and
CDC through a more recent expansion to the 2009 Tobacco Control
Act. This manuscript provides some analytical information that speaks
to addressing this potential regulatory challenge for non-tobacco
smoking products.